Abstract
Immunoassays using affinity binders such as antibodies and aptamers are crucial for molecular biology. However, the advancement of analytical methods based on these affinity probes is often hampered by complex operational steps that can introduce errors, particularly in intricate environments such as intracellular settings and microfluidic systems. There is growing interest in developing molecular probes for wash-free assays that activate signals upon target detection. Here we report a systematic functional screening platform for switchable aptamer beacon probes that can achieve target-responsive detection. A stem–loop, hairpin-shaped beacon library was constructed on microbeads and screened using target-responsive fluorescence-activated sorting. The selected aptamer beacons exhibit strong affinities, triggering fluorescence only upon binding, thus enabling wash-free immunoassays for the detection of intracellular and membrane proteins. Computational modelling offers insights into aptamer binding and structural switching mechanisms, revealing how specific protein–aptamer interactions drive stem–loop unwinding and postbinding conformational changes critical for functional activation. This approach establishes a standardized platform for generating switchable aptameric tools, supporting their potential in advanced diagnostics and research.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout








Similar content being viewed by others
Data availability
The crystal structure of the HER2 ECD (PDB ID: 6BGT) obtained from the Protein Data Bank47 was supplemented with missing residues spanning positions 22–132, 603–609 and 629–652 using the Homology Model module integrated into the MOE2019 software (https://www.chemcomp.com/en/Products.htm). The main data supporting the results in this study are available within the article and its Supplementary Information. Source data are provided with this paper. The sequencing data files are too large to be publicly shared, but they are available from the corresponding author upon reasonable request. All other data generated in this study are available via figshare at https://doi.org/10.6084/m9.figshare.28934987 (ref. 54).
References
Flynn, C. D. et al. Biomolecular sensors for advanced physiological monitoring. Nat. Rev. Bioeng. 1, 560–575 (2023).
Kuru, E. et al. Rapid discovery and evolution of nanosensors containing fluorogenic amino acids. Nat. Commun. 15, 7531 (2024).
Zhang, J. et al. A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat. Commun. 12, 5460 (2021).
Wang, D. & Tang, B. Z. Aggregation-induced emission luminogens for activity-based sensing. Acc. Chem. Res. 52, 2559–2570 (2019).
Zang, T. et al. In vitro light-up visualization of a subunit-specific enzyme by an AIE probe via restriction of single molecular motion. Angew. Chem. Int. Ed. Engl. 59, 10003–10007 (2020).
Feng, G. et al. When AIE meets enzymes. Analyst 147, 3958–3973 (2022).
Shi, X. et al. A red-emissive antibody-AIEgen conjugate for turn-on and wash-free imaging of specific cancer cells. Chem. Sci. 8, 7014–7024 (2017).
Wang, W. et al. Real-time imaging of cell-surface proteins with antibody-based fluorogenic probes. Chem. Sci. 12, 13477–13482 (2021).
Fu, H. J. et al. Rapid and wash-free time-gated FRET histamine assays using antibodies and aptamers. ACS Sens. 7, 1113–1121 (2022).
Dai, Y. et al. Intra Q-body: an antibody-based fluorogenic probe for intracellular proteins that allows live cell imaging and sorting. Chem. Sci. 13, 9739–9748 (2022).
Jeong, H. J. et al. Development of a quenchbody for the detection and imaging of the cancer-related tight-junction-associated membrane protein claudin. Anal. Chem. 89, 10783–10789 (2017).
Abe, R. et al. “Quenchbodies”: quench-based antibody probes that show antigen-dependent fluorescence. J. Am. Chem. Soc. 133, 17386–17394 (2011).
Peng, Q., Xiong, T., Ji, F., Ren, J. & Jia, L. Reduction-activatable fluorogenic nanobody for targeted and low-background bioimaging. Anal. Chem. 95, 2804–2811 (2023).
Kobayashi, T. et al. Highly activatable and environment-insensitive optical highlighters for selective spatiotemporal imaging of target proteins. J. Am. Chem. Soc. 134, 11153–11160 (2012).
Yoshikawa, A. M. et al. A massively parallel screening platform for converting aptamers into molecular switches. Nat. Commun. 14, 2336 (2023).
Poudineh, M. et al. A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals. Nat. Biomed. Eng. 5, 53–63 (2021).
Kolpashchikov, D. M. & Spelkov, A. A. Binary (split) light-up aptameric sensors. Angew. Chem. Int. Ed. Engl. 60, 4988–4999 (2021).
Chang, D. et al. Functional nucleic acids for pathogenic bacteria detection. Acc. Chem. Res. 54, 3540–3549 (2021).
Zhang, Z., Sen, P., Adhikari, B. R., Li, Y. & Soleymani, L. Development of nucleic-acid-based electrochemical biosensors for clinical applications. Angew. Chem. Int. Ed. Engl. 61, e202212496 (2022).
Moutsiopoulou, A., Broyles, D., Dikici, E., Daunert, S. & Deo, S. K. Molecular aptamer beacons and their applications in sensing, imaging, and diagnostics. Small 15, e1902248 (2019).
Fang, C. et al. Signal-on fluorescence biosensor for highly sensitive detection of miRNA-21 based on DNAzyme assisted double-hairpin molecular beacon. Biosensors 12, 276 (2022).
Wolfe, M. et al. Rational approach to optimizing conformation-switching aptamers for biosensing applications. ACS Sens. 9, 717–725 (2024).
Shi, Y. K. et al. A demethylation-switchable aptamer design enables lag-free monitoring of m6A demethylase FTO with energy self-sufficient and structurally integrated features. J. Am. Chem. Soc. 146, 34638–34650 (2024).
Deng, J., Liu, C. & Sun, J. DNA-based nanomaterials for analysis of extracellular vesicles. Adv. Mater. 36, e2303092 (2023).
Ji, C. et al. Aptamer–protein interactions: from regulation to biomolecular detection. Chem. Rev. 123, 12471–12506 (2023).
Kong, D., Thompson, I. A. P., Maganzini, N., Eisenstein, M. & Soh, H. T. Aptamer–antibody chimera sensors for sensitive, rapid, and reversible molecular detection in complex samples. ACS Sens. 9, 1168–1177 (2024).
Seo, J. W. et al. Real-time monitoring of drug pharmacokinetics within tumor tissue in live animals. Sci. Adv. 8, eabk2901 (2022).
Li, Y. et al. Molecular identification of tumor-derived extracellular vesicles using thermophoresis-mediated DNA computation. J. Am. Chem. Soc. 143, 1290–1295 (2021).
Deng, J. et al. One-step thermophoretic AND gate operation on extracellular vesicles improves diagnosis of prostate cancer. Angew. Chem. Int. Ed. Engl. 61, e202207037 (2022).
Xie, S. et al. Aptamer-based optical manipulation of protein subcellular localization in cells. Nat. Commun. 11, 1347 (2020).
Tan, J. et al. Electron transfer-triggered imaging of EGFR signaling activity. Nat. Commun. 13, 594 (2022).
Nakatsuka, N. et al. Aptamer-field-effect transistors overcome Debye length limitations for small-molecule sensing. Science 362, 319–324 (2018).
Wang, B. et al. Wearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoring. Sci. Adv. 8, eabk0967 (2022).
Zhao, C. et al. Implantable aptamer-field-effect transistor neuroprobes for in vivo neurotransmitter monitoring. Sci. Adv. 7, eabj7422 (2021).
Feng, Q. et al. A fluorogenic DNAzyme for a thermally stable protein biomarker from Fusobacterium nucleatum, a human bacterial pathogen. Angew. Chem. Int. Ed. Engl. 62, e202306272 (2023).
Zhou, Q. et al. In vitro selection of M(2+)-independent, fast-responding acidic deoxyribozymes for bacterial detection. J. Am. Chem. Soc. 145, 21370–21377 (2023).
Hu, Q. et al. DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance. Nat. Chem. 16, 122–131 (2024).
Li, J. et al. Functional aptamers in vitro evolution for intranuclear blockage of RNA–protein interaction. J. Am. Chem. Soc. 146, 24654–24662 (2024).
Wu, D., Gordon, C. K. L., Shin, J. H., Eisenstein, M. & Soh, H. T. Directed evolution of aptamer discovery technologies. Acc. Chem. Res. 55, 685–695 (2022).
Wang, J. et al. Particle display: a quantitative screening method for generating high-affinity aptamers. Angew. Chem. Int. Ed. Engl. 53, 4796–4801 (2014).
Wang, J. et al. Multiparameter particle display (MPPD): a quantitative screening method for the discovery of highly specific aptamers. Angew. Chem. Int. Ed. Engl. 56, 744–747 (2017).
Li, X., Zhao, L., Chen, C., Nie, J. & Jiao, B. Can EGFR be a therapeutic target in breast cancer? Biochim. Biophys. Acta Rev. Cancer 1877, 188789 (2022).
Wang, M. et al. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Clin. Transl. Oncol. 20, 906–911 (2018).
Kitano, K., Kim, S. Y. & Hakoshima, T. Structural basis for DNA strand separation by the unconventional winged-helix domain of RecQ helicase WRN. Structure 18, 177–187 (2010).
Deng, X. et al. Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes. PLoS ONE 9, e106448 (2014).
Niazi, S., Purohit, M., Sonawani, A. & Niazi, J. H. Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: an assessment. J. Mol. Graph. Model. 83, 112–121 (2018).
Berman, H., Henrick, K. & Nakamura, H. Announcing the worldwide Protein Data Bank. Nat. Struct. Biol. 10, 980 (2003).
Laio, A. & Parrinello, M. Escaping free-energy minima. Proc. Natl Acad. Sci. USA 99, 12562–12566 (2002).
Piana, S. & Laio, A. A bias-exchange approach to protein folding. J. Phys. Chem. B 111, 4553–4559 (2007).
Marinelli, F., Pietrucci, F., Laio, A. & Piana, S. A kinetic model of trp-cage folding from multiple biased molecular dynamics simulations. PLoS Comput. Biol. 5, e1000452 (2009).
Tian, C. et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528–552 (2020).
Galindo-Murillo, R. et al. Assessing the current state of Amber force field modifications for DNA. J. Chem. Theory Comput. 12, 4114–4127 (2016).
Liu, W., Liu, Z., Liu, H., Westerhoff, L. M. & Zheng, Z. Free energy calculations using the movable type method with molecular dynamics driven protein–ligand sampling. J. Chem. Inf. Model. 62, 5645–5665 (2022).
Cheng, X., Yao, P. & Zhang, L. Systematic functional screening of switchable aptamer probes—data sets. figshare https://doi.org/10.6084/m9.figshare.28934987 (2025).
Acknowledgements
We thank J. Sun from the National Center for Nanoscience and Technology, China, and X. Fang from the Hangzhou Institute of Medicine, Chinese Academy of Sciences, for their long-term collaboration and insightful discussions. We also extend our thanks to the staff at the Peking University Medical and Health Analysis Center and the State Key Laboratory of Natural and Biomimetic Drugs for their invaluable assistance with instrumental analysis. L.Z. discloses support for the research described in this study from the National Key R&D Program of China (grant nos. 2022YFA1304501 and 2023YFF1205902), the National Natural Science Foundation of China (grant nos. 22227805 and 22374004) and Excellent Young Scientists Fund Program (Overseas).
Author information
Authors and Affiliations
Contributions
X.C., P.Y. and L.Z. conceptualized and designed the research. X.C., P.Y., C.J., X.Z., T.W., Q.L., Y.C., H.S., H.X. and S.B. performed the experiments. X.C., P.Y. and L.Z. analysed the experimental data. W.L. and Z.Z. conducted computations. P.Y., X.C., W.L., Z.Z. and L.Z. prepared the figures and wrote the paper. All authors discussed the results and commented on the paper. L.Z. guided and supervised the research.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Biomedical Engineering thanks Hyun Gyu Park, Hao Yan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Schematic illustration and flow cytometry validation of the library construction.
The monoclonal microbeads library of aptamer beacons screening was constructed by emulsion PCR amplification, restriction enzyme-enabled site-specific modification, and exonuclease-digested single-strand generation, which were tested on primer-immobilized microbeads using. The library comprises a randomized region (pink), forward primers (blue and yellow), and reverse primer binding sites (yellow and green). Intramolecular complementary regions (yellow) and restriction enzyme cutting sites (letters) are embedded within. Fluorophores and quenchers are both attached onto dU bases.
Extended Data Fig. 2 Predicted structures of selected aptamer beacons against IL-2.
Each aptamer beacon for HER2 are illustrated by the predicted 2D structure (http://www.unafold.org/mfold/applications/dna-folding-form.php) and predicted 3D structure (http://biophy.hust.edu.cn/new/3dRNA/create).
Extended Data Fig. 3 Concentration-dependent fluorescence restoration of selected aptamer beacons (Cy3 and BHQ1) in response to gradient concentration of IL-2.
a, The target protein bound to the aptamer beacon, and the fluorescence of the aptamer beacon was restored. b, The fluorescence of AB-I2 was related to the change in the concentration of the target protein. c, The fluorescence of AB-I5 was related to the change in the concentration of the target protein. d, The fluorescence of AB-I5 was related to the change in the concentration of the target protein.
Extended Data Fig. 4 Specificity of AB-I2 Across Different Cell Types.
a, AB-I2 does not respond to cytokines produced by Raji cells. Experiments were performed in triplicate. Data are expressed as mean ± s.d of biological replicates. (t test statistic, two tailed, n = 3) b, AB-I2 does not respond to cytokines produced by THP-1 cells. Experiments were performed in triplicate. Data are expressed as mean ± s.d of biological replicate. (t test statistic, two tailed, n = 3).
Extended Data Fig. 5 Intracellular cytokine monitoring.
a, Selection of infectious agents. Using Lipofectamine 3000 to transfect AB-I2 into Jurkat cells, the distinction between activated and non-activated Jurkat cells can be achieved. b, Observation of the specific processes of activated and non-activated Jurkat cells through confocal microscopy. Lipofectamine 3000 was used to transfect AB-i2 into Jurkat cells that had been treated with ConA and Brefeldin A for 3 hours. After incubation for 1 hour, the cells were observed under a confocal microscope. c, Activated Jurkat cells can be observed under a confocal microscope with more obvious fluorescence than inactivated Jurkat cells. Three fields of view were randomly selected for each sample for shooting. Due to limited space, only one of the fields of view is shown here.
Extended Data Fig. 6 Predicted structures of selected aptamer beacons against HER2.
Each aptamer beacon for HER2 are illustrated by the predicted 2D structure (http://www.unafold.org/mfold/applications/dna-folding-form.php) and predicted 3D structure (http://biophy.hust.edu.cn/new/3dRNA/create).
Extended Data Fig. 7 Further characterization of AB-H10 interaction with HER2 protein.
a, Schematic diagram illustrating the principle of Pull-Down experiments to validate probe targets. Cells were lysed, and membrane proteins were extracted and incubated with biotinylated aptamer beacons, followed by capturing by streptavidin-coated microbeads. The complex was resolved by SDS-PAGE. b, Conducting Pull-Down experiments using various aptamer beacons on HER2( + ) AU565 cells, followed by Western Blot experiments with HER2 antibodies to confirm the protein bands originating from HER2.This experiment was repeated once with similar results. c, Schematic illustration of AB-H10 incubated with protein-immobilized microbeads. d, AB-H10 specifically binds to HER2-immobilized beads rather than EGFR-immobilized beads or empty beads.
Extended Data Fig. 8 Estimation of the half-life of aptamer beacons in different solution systems.
a, the half-life of AB-I2 in PBS. b, the half-life of AB-I2 in Binding Buffer. c, the half-life of AB-I2 in DMEM. d, the half-life of AB-I2 in DMEM + 10%FBS. e, the half-life of AB-H10 in PBS. f, the half-life of AB-H10 in Binding Buffer. g, the half-life of AB-H10 in DMEM.h, the half-life of AB-H10 in DMEM + 10%FBS. The solutions were sampled at different time points with three biological replicates, and fluorescence was detected using BioTek equipment. Data are expressed as mean ± s.d of biological replicates. The concentrations of AB-I2 and AB-H10 were 500 nM, and the incubation was performed at 37 °C. The solutions were analyzed by running them on a 15% PAGE gel, which was then stained with GelRed dye.
Extended Data Fig. 9 Intracellular Stability Estimation for AB-I2.
a, Estimate of the intracellular half-life of AB-I2 delivered by Lipo3000. Changes in fluorescence intensity of Cy3 in cells over incubation time. b, Intracellular degradation curve of AB-I2. Experiments were performed in triplicate. Data are expressed as mean ± s.d of biological replicates. c, Prediction of the Tm value of AB-I2 under intracellular ion concentrations. (http://www.unafold.org/mfold/applications/dna-folding-form.php).
Extended Data Fig. 10 Prediction and estimation of the melting temperature of AB-I2 and AB-H10.
a, Prediction and estimate of Tm value of AB-I2 in PBS. b, Prediction and estimate of Tm value of AB-I2 in Binding Buffer. c, Prediction and estimate of Tm value of AB-I2 in DMEM. d, Prediction and estimate of Tm value of AB-H10 in PBS. e, Prediction and estimate of Tm value of AB-H10 in Binding Buffer. f, Prediction and estimate of Tm value of AB-H10 in DMEM. (http://www.unafold.org/mfold/applications/dna-folding-form.php) Experiments were performed in triplicate. Data are expressed as mean ± s.d of biological replicates.
Supplementary information
Supplementary Information
Supplementary Figs. 1–4 and Tables 1–12.
Supplementary Video 1
Simulation of the mechanism of the HER2 aptamer beacon. Left: a 1-μs metadynamics simulation revealed the molecular mechanism of AB-H10 base-pair separation at the HER2 ECD binding site. Right: an unwound AB-H10 structure was generated using a protein structure modelling program, RoseTTAFold, and refined with a 10-ns MD simulation.
Source data
Source Data Fig. 2
Statistical source data and unprocessed gels.
Source Data Fig. 4
Statistical source data.
Source Data Fig. 8
Statistical source data.
Source Data Extended Data Fig. 4
Statistical source data.
Source Data Extended Data Fig. 7
Unprocessed gels.
Source Data Extended Data Fig. 8
Statistical source data and unprocessed gels.
Source Data Extended Data Fig. 9
Statistical source data.
Source Data Extended Data Fig. 10
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cheng, X., Yao, P., Jin, C. et al. Systematic functional screening of switchable aptamer beacon probes. Nat. Biomed. Eng (2025). https://doi.org/10.1038/s41551-025-01503-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41551-025-01503-8